For patients with triple negative breast cancer, currently undergoing neoadjuvant dd AC, would you consider adding pembrolizumab to weekly paclitaxel based on recent KEYNOTE-522 and continue as adjuvant?  


Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at Colorado Permanente Medical Group Hematology & Oncology
Thanks for posing and answering this important que...
Medical Oncologist at Mayo Clinic
This is, of course, a data-free zone and has lots ...
Medical Oncologist at Kettering Cancer Center
Dr. @Roberto A. Leon-Ferre, what is the current ro...
Sign in or Register to read more

Answer from: Medical Oncologist at Academic Institution